Author:
Zhu Bing,Jin Shengwei,Wu Lianpeng,Hu Chenchan,Wang Zhen,Bu Le,Sun Hang,Wang Xingchun,Qu Shen,Chen Dong
Funder
National Key R&D Program of China
National Natural Science Foundation of China
Key Scientific and Technological Innovation Projects of Wenzhou
University of Sydney
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference33 articles.
1. Murdoch DR Clinical course and mortality risk of severe COVID-19;Weiss;Lancet,2020
2. Khunti K Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: a narrative review;Singh;Diabetes Res Clin Pract,2020
3. Diabetes is a risk factor for the progression and prognosis of COVID-19;Guo;Diabetes Metab Res Rev,2020
4. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes;Zhu;Cell Metab,2020
5. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations;Singh;Diabetes Metab Syndr,2020
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献